イトプリド塩酸塩錠のグローバル市場予測2023-2029

◆英語タイトル:Global Itopride Hydrochloride Tablets Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23OT9038)◆商品コード:LP23OT9038
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年10月
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「イトプリド塩酸塩錠のグローバル市場」は、過去の販売実績から2022年の世界のイトプリド塩酸塩錠の総販売量を検討し、2023年から2029年の予測されるイトプリド塩酸塩錠の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のイトプリド塩酸塩錠の市場規模を掲載し、XXX百万米ドル規模の世界のイトプリド塩酸塩錠市場の詳細な分析を提供します。本インサイトレポートは、世界のイトプリド塩酸塩錠業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のイトプリド塩酸塩錠市場における各社の独自のポジションをより深く理解するために、イトプリド塩酸塩錠製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のイトプリド塩酸塩錠市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。イトプリド塩酸塩錠の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。イトプリド塩酸塩錠の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。イトプリド塩酸塩錠のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

イトプリド塩酸塩錠の世界主要メーカーとしては、Abbott Laboratories、 Nichi-iko Pharmaceutical Co.,Ltd、 Tsubame Labo, Inc、 Livzon Pharmaceutical Group Inc、 Jiangsu Hengrui Pharmaceuticals Co., Ltd、 Zhuhai Rundu Pharmaceutical Co.,Ltd、 HARBIN PHARMACEUTICAL GROUP CO.,LTD、 Liaoning Gaoxin Pharmaceutical Co., Ltd、 Suzhou Amyjin Pharmaceutical Co., Ltd、 Yunnan Yong’an Pharmaceutical Co., Ltd、 Disha Pharmaceutical Group Co., Ltdなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のイトプリド塩酸塩錠市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査ではイトプリド塩酸塩錠市場をセグメンテーションし、種類別 (12個/箱、20個/箱、その他)、用途別 (心窩部不快感、食後膨満感、食欲不振、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:12個/箱、20個/箱、その他

・用途別区分:心窩部不快感、食後膨満感、食欲不振、その他

・地域別区分
南北アメリカ(米国、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のイトプリド塩酸塩錠市場の10年間の市場状況・展望は?
・世界および地域別に見たイトプリド塩酸塩錠市場成長の要因は何か?
・イトプリド塩酸塩錠の市場機会はエンドマーケットの規模によってどのように変化するのか?
・イトプリド塩酸塩錠のタイプ別、用途別の内訳は?
・新型コロナウイルスとロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:イトプリド塩酸塩錠の年間販売量2018-2029、地域別現状・将来分析
・イトプリド塩酸塩錠の種類別セグメント:12個/箱、20個/箱、その他
・イトプリド塩酸塩錠の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・イトプリド塩酸塩錠の用途別セグメント:心窩部不快感、食後膨満感、食欲不振、その他
・イトプリド塩酸塩錠の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のイトプリド塩酸塩錠市場
・企業別のグローバルイトプリド塩酸塩錠市場データ:2018-2023年の年間販売量、市場シェア
・企業別のイトプリド塩酸塩錠の年間売上:2018-2023年の売上、市場シェア
・企業別のイトプリド塩酸塩錠販売価格
・主要企業のイトプリド塩酸塩錠生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

イトプリド塩酸塩錠の地域別レビュー
・地域別のイトプリド塩酸塩錠市場規模2018-2023:年間販売量、売上
・主要国別のイトプリド塩酸塩錠市場規模2018-2023:年間販売量、売上
・南北アメリカのイトプリド塩酸塩錠販売の成長
・アジア太平洋のイトプリド塩酸塩錠販売の成長
・ヨーロッパのイトプリド塩酸塩錠販売の成長
・中東・アフリカのイトプリド塩酸塩錠販売の成長

南北アメリカ市場
・南北アメリカの国別のイトプリド塩酸塩錠販売量、売上(2018-2023)
・南北アメリカのイトプリド塩酸塩錠の種類別販売量
・南北アメリカのイトプリド塩酸塩錠の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のイトプリド塩酸塩錠販売量、売上(2018-2023)
・アジア太平洋のイトプリド塩酸塩錠の種類別販売量
・アジア太平洋のイトプリド塩酸塩錠の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のイトプリド塩酸塩錠販売量、売上(2018-2023)
・ヨーロッパのイトプリド塩酸塩錠の種類別販売量
・ヨーロッパのイトプリド塩酸塩錠の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のイトプリド塩酸塩錠販売量、売上(2018-2023)
・中東・アフリカのイトプリド塩酸塩錠の種類別販売量
・中東・アフリカのイトプリド塩酸塩錠の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・イトプリド塩酸塩錠の製造コスト構造分析
・イトプリド塩酸塩錠の製造プロセス分析
・イトプリド塩酸塩錠の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・イトプリド塩酸塩錠の主要なグローバル販売業者
・イトプリド塩酸塩錠の主要なグローバル顧客

地域別のイトプリド塩酸塩錠市場予測レビュー
・地域別のイトプリド塩酸塩錠市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・イトプリド塩酸塩錠の種類別市場規模予測
・イトプリド塩酸塩錠の用途別市場規模予測

主要企業分析
Abbott Laboratories、 Nichi-iko Pharmaceutical Co.,Ltd、 Tsubame Labo, Inc、 Livzon Pharmaceutical Group Inc、 Jiangsu Hengrui Pharmaceuticals Co., Ltd、 Zhuhai Rundu Pharmaceutical Co.,Ltd、 HARBIN PHARMACEUTICAL GROUP CO.,LTD、 Liaoning Gaoxin Pharmaceutical Co., Ltd、 Suzhou Amyjin Pharmaceutical Co., Ltd、 Yunnan Yong’an Pharmaceutical Co., Ltd、 Disha Pharmaceutical Group Co., Ltd
・企業情報
・イトプリド塩酸塩錠製品
・イトプリド塩酸塩錠販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Itopride Hydrochloride Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Itopride Hydrochloride Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Itopride Hydrochloride Tablets by Country/Region, 2018, 2022 & 2029
2.2 Itopride Hydrochloride Tablets Segment by Type
2.2.1 12pieces/box
2.2.2 20 pieces/box
2.2.3 Others
2.3 Itopride Hydrochloride Tablets Sales by Type
2.3.1 Global Itopride Hydrochloride Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Itopride Hydrochloride Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Itopride Hydrochloride Tablets Sale Price by Type (2018-2023)
2.4 Itopride Hydrochloride Tablets Segment by Application
2.4.1 Epigastric Discomfort
2.4.2 Postprandial Fullness
2.4.3 Loss Of Appetite
2.4.4 Others
2.5 Itopride Hydrochloride Tablets Sales by Application
2.5.1 Global Itopride Hydrochloride Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Itopride Hydrochloride Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Itopride Hydrochloride Tablets Sale Price by Application (2018-2023)
3 Global Itopride Hydrochloride Tablets by Company
3.1 Global Itopride Hydrochloride Tablets Breakdown Data by Company
3.1.1 Global Itopride Hydrochloride Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Itopride Hydrochloride Tablets Sales Market Share by Company (2018-2023)
3.2 Global Itopride Hydrochloride Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Itopride Hydrochloride Tablets Revenue by Company (2018-2023)
3.2.2 Global Itopride Hydrochloride Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Itopride Hydrochloride Tablets Sale Price by Company
3.4 Key Manufacturers Itopride Hydrochloride Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Itopride Hydrochloride Tablets Product Location Distribution
3.4.2 Players Itopride Hydrochloride Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Itopride Hydrochloride Tablets by Geographic Region
4.1 World Historic Itopride Hydrochloride Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Itopride Hydrochloride Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Itopride Hydrochloride Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Itopride Hydrochloride Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Itopride Hydrochloride Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Itopride Hydrochloride Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Itopride Hydrochloride Tablets Sales Growth
4.4 APAC Itopride Hydrochloride Tablets Sales Growth
4.5 Europe Itopride Hydrochloride Tablets Sales Growth
4.6 Middle East & Africa Itopride Hydrochloride Tablets Sales Growth
5 Americas
5.1 Americas Itopride Hydrochloride Tablets Sales by Country
5.1.1 Americas Itopride Hydrochloride Tablets Sales by Country (2018-2023)
5.1.2 Americas Itopride Hydrochloride Tablets Revenue by Country (2018-2023)
5.2 Americas Itopride Hydrochloride Tablets Sales by Type
5.3 Americas Itopride Hydrochloride Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Itopride Hydrochloride Tablets Sales by Region
6.1.1 APAC Itopride Hydrochloride Tablets Sales by Region (2018-2023)
6.1.2 APAC Itopride Hydrochloride Tablets Revenue by Region (2018-2023)
6.2 APAC Itopride Hydrochloride Tablets Sales by Type
6.3 APAC Itopride Hydrochloride Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Itopride Hydrochloride Tablets by Country
7.1.1 Europe Itopride Hydrochloride Tablets Sales by Country (2018-2023)
7.1.2 Europe Itopride Hydrochloride Tablets Revenue by Country (2018-2023)
7.2 Europe Itopride Hydrochloride Tablets Sales by Type
7.3 Europe Itopride Hydrochloride Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Itopride Hydrochloride Tablets by Country
8.1.1 Middle East & Africa Itopride Hydrochloride Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Itopride Hydrochloride Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Itopride Hydrochloride Tablets Sales by Type
8.3 Middle East & Africa Itopride Hydrochloride Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Itopride Hydrochloride Tablets
10.3 Manufacturing Process Analysis of Itopride Hydrochloride Tablets
10.4 Industry Chain Structure of Itopride Hydrochloride Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Itopride Hydrochloride Tablets Distributors
11.3 Itopride Hydrochloride Tablets Customer
12 World Forecast Review for Itopride Hydrochloride Tablets by Geographic Region
12.1 Global Itopride Hydrochloride Tablets Market Size Forecast by Region
12.1.1 Global Itopride Hydrochloride Tablets Forecast by Region (2024-2029)
12.1.2 Global Itopride Hydrochloride Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Itopride Hydrochloride Tablets Forecast by Type
12.7 Global Itopride Hydrochloride Tablets Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.1.3 Abbott Laboratories Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Nichi-iko Pharmaceutical Co.,Ltd
13.2.1 Nichi-iko Pharmaceutical Co.,Ltd Company Information
13.2.2 Nichi-iko Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.2.3 Nichi-iko Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nichi-iko Pharmaceutical Co.,Ltd Main Business Overview
13.2.5 Nichi-iko Pharmaceutical Co.,Ltd Latest Developments
13.3 Tsubame Labo, Inc
13.3.1 Tsubame Labo, Inc Company Information
13.3.2 Tsubame Labo, Inc Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.3.3 Tsubame Labo, Inc Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Tsubame Labo, Inc Main Business Overview
13.3.5 Tsubame Labo, Inc Latest Developments
13.4 Livzon Pharmaceutical Group Inc
13.4.1 Livzon Pharmaceutical Group Inc Company Information
13.4.2 Livzon Pharmaceutical Group Inc Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.4.3 Livzon Pharmaceutical Group Inc Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Livzon Pharmaceutical Group Inc Main Business Overview
13.4.5 Livzon Pharmaceutical Group Inc Latest Developments
13.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd
13.5.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
13.5.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.5.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Main Business Overview
13.5.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Latest Developments
13.6 Zhuhai Rundu Pharmaceutical Co.,Ltd
13.6.1 Zhuhai Rundu Pharmaceutical Co.,Ltd Company Information
13.6.2 Zhuhai Rundu Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.6.3 Zhuhai Rundu Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zhuhai Rundu Pharmaceutical Co.,Ltd Main Business Overview
13.6.5 Zhuhai Rundu Pharmaceutical Co.,Ltd Latest Developments
13.7 HARBIN PHARMACEUTICAL GROUP CO.,LTD
13.7.1 HARBIN PHARMACEUTICAL GROUP CO.,LTD Company Information
13.7.2 HARBIN PHARMACEUTICAL GROUP CO.,LTD Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.7.3 HARBIN PHARMACEUTICAL GROUP CO.,LTD Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 HARBIN PHARMACEUTICAL GROUP CO.,LTD Main Business Overview
13.7.5 HARBIN PHARMACEUTICAL GROUP CO.,LTD Latest Developments
13.8 Liaoning Gaoxin Pharmaceutical Co., Ltd
13.8.1 Liaoning Gaoxin Pharmaceutical Co., Ltd Company Information
13.8.2 Liaoning Gaoxin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.8.3 Liaoning Gaoxin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Liaoning Gaoxin Pharmaceutical Co., Ltd Main Business Overview
13.8.5 Liaoning Gaoxin Pharmaceutical Co., Ltd Latest Developments
13.9 Suzhou Amyjin Pharmaceutical Co., Ltd
13.9.1 Suzhou Amyjin Pharmaceutical Co., Ltd Company Information
13.9.2 Suzhou Amyjin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.9.3 Suzhou Amyjin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Suzhou Amyjin Pharmaceutical Co., Ltd Main Business Overview
13.9.5 Suzhou Amyjin Pharmaceutical Co., Ltd Latest Developments
13.10 Yunnan Yong’an Pharmaceutical Co., Ltd
13.10.1 Yunnan Yong’an Pharmaceutical Co., Ltd Company Information
13.10.2 Yunnan Yong’an Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.10.3 Yunnan Yong’an Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Yunnan Yong’an Pharmaceutical Co., Ltd Main Business Overview
13.10.5 Yunnan Yong’an Pharmaceutical Co., Ltd Latest Developments
13.11 Disha Pharmaceutical Group Co., Ltd
13.11.1 Disha Pharmaceutical Group Co., Ltd Company Information
13.11.2 Disha Pharmaceutical Group Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
13.11.3 Disha Pharmaceutical Group Co., Ltd Itopride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Disha Pharmaceutical Group Co., Ltd Main Business Overview
13.11.5 Disha Pharmaceutical Group Co., Ltd Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Itopride Hydrochloride Tablets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Itopride Hydrochloride Tablets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 12pieces/box
Table 4. Major Players of 20 pieces/box
Table 5. Major Players of Others
Table 6. Global Itopride Hydrochloride Tablets Sales by Type (2018-2023) & (K Units)
Table 7. Global Itopride Hydrochloride Tablets Sales Market Share by Type (2018-2023)
Table 8. Global Itopride Hydrochloride Tablets Revenue by Type (2018-2023) & ($ million)
Table 9. Global Itopride Hydrochloride Tablets Revenue Market Share by Type (2018-2023)
Table 10. Global Itopride Hydrochloride Tablets Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Itopride Hydrochloride Tablets Sales by Application (2018-2023) & (K Units)
Table 12. Global Itopride Hydrochloride Tablets Sales Market Share by Application (2018-2023)
Table 13. Global Itopride Hydrochloride Tablets Revenue by Application (2018-2023)
Table 14. Global Itopride Hydrochloride Tablets Revenue Market Share by Application (2018-2023)
Table 15. Global Itopride Hydrochloride Tablets Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Itopride Hydrochloride Tablets Sales by Company (2018-2023) & (K Units)
Table 17. Global Itopride Hydrochloride Tablets Sales Market Share by Company (2018-2023)
Table 18. Global Itopride Hydrochloride Tablets Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Itopride Hydrochloride Tablets Revenue Market Share by Company (2018-2023)
Table 20. Global Itopride Hydrochloride Tablets Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Itopride Hydrochloride Tablets Producing Area Distribution and Sales Area
Table 22. Players Itopride Hydrochloride Tablets Products Offered
Table 23. Itopride Hydrochloride Tablets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Itopride Hydrochloride Tablets Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Itopride Hydrochloride Tablets Sales Market Share Geographic Region (2018-2023)
Table 28. Global Itopride Hydrochloride Tablets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Itopride Hydrochloride Tablets Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Itopride Hydrochloride Tablets Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Itopride Hydrochloride Tablets Sales Market Share by Country/Region (2018-2023)
Table 32. Global Itopride Hydrochloride Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Itopride Hydrochloride Tablets Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Itopride Hydrochloride Tablets Sales by Country (2018-2023) & (K Units)
Table 35. Americas Itopride Hydrochloride Tablets Sales Market Share by Country (2018-2023)
Table 36. Americas Itopride Hydrochloride Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Itopride Hydrochloride Tablets Revenue Market Share by Country (2018-2023)
Table 38. Americas Itopride Hydrochloride Tablets Sales by Type (2018-2023) & (K Units)
Table 39. Americas Itopride Hydrochloride Tablets Sales by Application (2018-2023) & (K Units)
Table 40. APAC Itopride Hydrochloride Tablets Sales by Region (2018-2023) & (K Units)
Table 41. APAC Itopride Hydrochloride Tablets Sales Market Share by Region (2018-2023)
Table 42. APAC Itopride Hydrochloride Tablets Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Itopride Hydrochloride Tablets Revenue Market Share by Region (2018-2023)
Table 44. APAC Itopride Hydrochloride Tablets Sales by Type (2018-2023) & (K Units)
Table 45. APAC Itopride Hydrochloride Tablets Sales by Application (2018-2023) & (K Units)
Table 46. Europe Itopride Hydrochloride Tablets Sales by Country (2018-2023) & (K Units)
Table 47. Europe Itopride Hydrochloride Tablets Sales Market Share by Country (2018-2023)
Table 48. Europe Itopride Hydrochloride Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Itopride Hydrochloride Tablets Revenue Market Share by Country (2018-2023)
Table 50. Europe Itopride Hydrochloride Tablets Sales by Type (2018-2023) & (K Units)
Table 51. Europe Itopride Hydrochloride Tablets Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Itopride Hydrochloride Tablets Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Itopride Hydrochloride Tablets Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Itopride Hydrochloride Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Itopride Hydrochloride Tablets Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Itopride Hydrochloride Tablets Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Itopride Hydrochloride Tablets Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Itopride Hydrochloride Tablets
Table 59. Key Market Challenges & Risks of Itopride Hydrochloride Tablets
Table 60. Key Industry Trends of Itopride Hydrochloride Tablets
Table 61. Itopride Hydrochloride Tablets Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Itopride Hydrochloride Tablets Distributors List
Table 64. Itopride Hydrochloride Tablets Customer List
Table 65. Global Itopride Hydrochloride Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Itopride Hydrochloride Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Itopride Hydrochloride Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Itopride Hydrochloride Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Itopride Hydrochloride Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Itopride Hydrochloride Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Itopride Hydrochloride Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Itopride Hydrochloride Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Itopride Hydrochloride Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Itopride Hydrochloride Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Itopride Hydrochloride Tablets Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Itopride Hydrochloride Tablets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Itopride Hydrochloride Tablets Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Itopride Hydrochloride Tablets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Abbott Laboratories Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 80. Abbott Laboratories Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 81. Abbott Laboratories Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Abbott Laboratories Main Business
Table 83. Abbott Laboratories Latest Developments
Table 84. Nichi-iko Pharmaceutical Co.,Ltd Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 85. Nichi-iko Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 86. Nichi-iko Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Nichi-iko Pharmaceutical Co.,Ltd Main Business
Table 88. Nichi-iko Pharmaceutical Co.,Ltd Latest Developments
Table 89. Tsubame Labo, Inc Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 90. Tsubame Labo, Inc Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 91. Tsubame Labo, Inc Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Tsubame Labo, Inc Main Business
Table 93. Tsubame Labo, Inc Latest Developments
Table 94. Livzon Pharmaceutical Group Inc Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 95. Livzon Pharmaceutical Group Inc Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 96. Livzon Pharmaceutical Group Inc Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Livzon Pharmaceutical Group Inc Main Business
Table 98. Livzon Pharmaceutical Group Inc Latest Developments
Table 99. Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 100. Jiangsu Hengrui Pharmaceuticals Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 101. Jiangsu Hengrui Pharmaceuticals Co., Ltd Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Jiangsu Hengrui Pharmaceuticals Co., Ltd Main Business
Table 103. Jiangsu Hengrui Pharmaceuticals Co., Ltd Latest Developments
Table 104. Zhuhai Rundu Pharmaceutical Co.,Ltd Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 105. Zhuhai Rundu Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 106. Zhuhai Rundu Pharmaceutical Co.,Ltd Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Zhuhai Rundu Pharmaceutical Co.,Ltd Main Business
Table 108. Zhuhai Rundu Pharmaceutical Co.,Ltd Latest Developments
Table 109. HARBIN PHARMACEUTICAL GROUP CO.,LTD Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 110. HARBIN PHARMACEUTICAL GROUP CO.,LTD Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 111. HARBIN PHARMACEUTICAL GROUP CO.,LTD Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. HARBIN PHARMACEUTICAL GROUP CO.,LTD Main Business
Table 113. HARBIN PHARMACEUTICAL GROUP CO.,LTD Latest Developments
Table 114. Liaoning Gaoxin Pharmaceutical Co., Ltd Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 115. Liaoning Gaoxin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 116. Liaoning Gaoxin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Liaoning Gaoxin Pharmaceutical Co., Ltd Main Business
Table 118. Liaoning Gaoxin Pharmaceutical Co., Ltd Latest Developments
Table 119. Suzhou Amyjin Pharmaceutical Co., Ltd Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 120. Suzhou Amyjin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 121. Suzhou Amyjin Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Suzhou Amyjin Pharmaceutical Co., Ltd Main Business
Table 123. Suzhou Amyjin Pharmaceutical Co., Ltd Latest Developments
Table 124. Yunnan Yong'an Pharmaceutical Co., Ltd Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 125. Yunnan Yong'an Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 126. Yunnan Yong'an Pharmaceutical Co., Ltd Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Yunnan Yong'an Pharmaceutical Co., Ltd Main Business
Table 128. Yunnan Yong'an Pharmaceutical Co., Ltd Latest Developments
Table 129. Disha Pharmaceutical Group Co., Ltd Basic Information, Itopride Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 130. Disha Pharmaceutical Group Co., Ltd Itopride Hydrochloride Tablets Product Portfolios and Specifications
Table 131. Disha Pharmaceutical Group Co., Ltd Itopride Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Disha Pharmaceutical Group Co., Ltd Main Business
Table 133. Disha Pharmaceutical Group Co., Ltd Latest Developments
List of Figures
Figure 1. Picture of Itopride Hydrochloride Tablets
Figure 2. Itopride Hydrochloride Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Itopride Hydrochloride Tablets Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Itopride Hydrochloride Tablets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Itopride Hydrochloride Tablets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 12pieces/box
Figure 10. Product Picture of 20 pieces/box
Figure 11. Product Picture of Others
Figure 12. Global Itopride Hydrochloride Tablets Sales Market Share by Type in 2022
Figure 13. Global Itopride Hydrochloride Tablets Revenue Market Share by Type (2018-2023)
Figure 14. Itopride Hydrochloride Tablets Consumed in Epigastric Discomfort
Figure 15. Global Itopride Hydrochloride Tablets Market: Epigastric Discomfort (2018-2023) & (K Units)
Figure 16. Itopride Hydrochloride Tablets Consumed in Postprandial Fullness
Figure 17. Global Itopride Hydrochloride Tablets Market: Postprandial Fullness (2018-2023) & (K Units)
Figure 18. Itopride Hydrochloride Tablets Consumed in Loss Of Appetite
Figure 19. Global Itopride Hydrochloride Tablets Market: Loss Of Appetite (2018-2023) & (K Units)
Figure 20. Itopride Hydrochloride Tablets Consumed in Others
Figure 21. Global Itopride Hydrochloride Tablets Market: Others (2018-2023) & (K Units)
Figure 22. Global Itopride Hydrochloride Tablets Sales Market Share by Application (2022)
Figure 23. Global Itopride Hydrochloride Tablets Revenue Market Share by Application in 2022
Figure 24. Itopride Hydrochloride Tablets Sales Market by Company in 2022 (K Units)
Figure 25. Global Itopride Hydrochloride Tablets Sales Market Share by Company in 2022
Figure 26. Itopride Hydrochloride Tablets Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Itopride Hydrochloride Tablets Revenue Market Share by Company in 2022
Figure 28. Global Itopride Hydrochloride Tablets Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Itopride Hydrochloride Tablets Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Itopride Hydrochloride Tablets Sales 2018-2023 (K Units)
Figure 31. Americas Itopride Hydrochloride Tablets Revenue 2018-2023 ($ Millions)
Figure 32. APAC Itopride Hydrochloride Tablets Sales 2018-2023 (K Units)
Figure 33. APAC Itopride Hydrochloride Tablets Revenue 2018-2023 ($ Millions)
Figure 34. Europe Itopride Hydrochloride Tablets Sales 2018-2023 (K Units)
Figure 35. Europe Itopride Hydrochloride Tablets Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Itopride Hydrochloride Tablets Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Itopride Hydrochloride Tablets Revenue 2018-2023 ($ Millions)
Figure 38. Americas Itopride Hydrochloride Tablets Sales Market Share by Country in 2022
Figure 39. Americas Itopride Hydrochloride Tablets Revenue Market Share by Country in 2022
Figure 40. Americas Itopride Hydrochloride Tablets Sales Market Share by Type (2018-2023)
Figure 41. Americas Itopride Hydrochloride Tablets Sales Market Share by Application (2018-2023)
Figure 42. United States Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Itopride Hydrochloride Tablets Sales Market Share by Region in 2022
Figure 47. APAC Itopride Hydrochloride Tablets Revenue Market Share by Regions in 2022
Figure 48. APAC Itopride Hydrochloride Tablets Sales Market Share by Type (2018-2023)
Figure 49. APAC Itopride Hydrochloride Tablets Sales Market Share by Application (2018-2023)
Figure 50. China Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Itopride Hydrochloride Tablets Sales Market Share by Country in 2022
Figure 58. Europe Itopride Hydrochloride Tablets Revenue Market Share by Country in 2022
Figure 59. Europe Itopride Hydrochloride Tablets Sales Market Share by Type (2018-2023)
Figure 60. Europe Itopride Hydrochloride Tablets Sales Market Share by Application (2018-2023)
Figure 61. Germany Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Itopride Hydrochloride Tablets Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Itopride Hydrochloride Tablets Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Itopride Hydrochloride Tablets Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Itopride Hydrochloride Tablets Sales Market Share by Application (2018-2023)
Figure 70. Egypt Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Itopride Hydrochloride Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Itopride Hydrochloride Tablets in 2022
Figure 76. Manufacturing Process Analysis of Itopride Hydrochloride Tablets
Figure 77. Industry Chain Structure of Itopride Hydrochloride Tablets
Figure 78. Channels of Distribution
Figure 79. Global Itopride Hydrochloride Tablets Sales Market Forecast by Region (2024-2029)
Figure 80. Global Itopride Hydrochloride Tablets Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Itopride Hydrochloride Tablets Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Itopride Hydrochloride Tablets Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Itopride Hydrochloride Tablets Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Itopride Hydrochloride Tablets Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ イトプリド塩酸塩錠のグローバル市場予測2023-2029(Global Itopride Hydrochloride Tablets Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆